“Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation”. 2020. Journal of Kidney Cancer 7 (1): 7-11. https://doi.org/10.15586/jkcvhl.2020.135.